Home
Pontifax Management 4 G.P. reported a 0% stake in Keros Therapeutics KROS · 0 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 0%
- Last report
- 11.8% · filed 25/04/18
- Shares held
- 0 sh
- Class
- Common Stock, Par Value $0.0001 Per Share
- Event date
- 25/10/15
- Filed
- 25/10/16
0% stake · fully exited
- Stake
- 0%
- Last report
- 11.8%
- Since last report
- −11.8pp
Keros Therapeutics trades, last 26 weeks
What else happened in Keros Therapeutics around then
Filed or reported within 30 days of the trade day · 25/09/15~25/11/14Pontifax Management 4 G.P.'s other 5% stake reports
- Pontifax Management 4 G.P.
5% stakeAgomAb Therapeutics
5% stakeAgomAb Therapeutics
AGMB
6.8% stake
3,305,846 sh
6.8% stake
Filed 04/16
- Pontifax Management 4 G.P.
5% stakeLB Pharmaceuticals
5% stakeLB Pharmaceuticals
LBRX
6.3% stake
1,411,681 sh
6.3% stake
Filed 25/09/25
- Pontifax Management 4 G.P.
5% stakeClimb Bio
5% stakeClimb Bio
CLYM
7.7% stake
5,206,380 sh
7.7% stake
Filed 25/09/18
- Pontifax Management 4 G.P.
5% stakeKeros Therapeutics
5% stakeKeros Therapeutics
KROS
11.8% stake
4,787,331 sh
11.8% stake
Filed 25/04/18
